Citigroup’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-476,900
Closed -$34.4M 6654
2022
Q1
$34.4M Sell
476,900
-115,000
-19% -$8.28M 0.02% 651
2021
Q4
$54.3M Buy
591,900
+473,300
+399% +$56.6M 0.03% 536
2021
Q3
$15M Buy
118,600
+38,600
+48% +$5.62M 0.01% 1174
2021
Q2
$13.3M Buy
80,000
+78,000
+3,900% +$12.6M 0.01% 1237
2021
Q1
$364K Sell
2,000
-40,708
-95% -$9.44M ﹤0.01% 3679
2020
Q4
$8.54M Sell
42,708
-5,092
-11% -$1.04M 0.01% 1692
2020
Q3
$10.5M Buy
47,800
+7,000
+17% +$1.48M 0.01% 1342
2020
Q2
$7.79M Buy
40,800
+6,000
+17% +$1.05M 0.01% 1501
2020
Q1
$5.39M Buy
34,800
+19,200
+123% +$2.23M ﹤0.01% 1603
2019
Q4
$1.31M Sell
15,600
-17,800
-53% -$1.35M ﹤0.01% 3473
2019
Q3
$2.26M Sell
33,400
-43,500
-57% -$2.86M ﹤0.01% 2724
2019
Q2
$5.11M Sell
76,900
-47,800
-38% -$2.79M ﹤0.01% 1954
2019
Q1
$6.93M Buy
124,700
+95,800
+331% +$5.85M 0.01% 1537
2018
Q4
$1.43M Buy
28,900
+23,400
+425% +$1.43M ﹤0.01% 3016
2018
Q3
$475K Buy
+5,500
New +$392K ﹤0.01% 4345

Other funds holding TDOC

Citigroup's TDOC Position: Q1 2026 in Review

Citigroup increased its Teladoc Health (TDOC) stake by 112% in Q1 2026, buying an estimated $95.8K and bringing the position to 32,364 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

Citigroup first reported a position in TDOC in Q3 2015 and has held it in 42 quarters since. The position peaked at $115M in Q3 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Citigroup held 32,364 shares of Teladoc Health worth $176K as of Q1 2026.
  • Citigroup bought 17,082 Teladoc Health shares in Q1 2026, an estimated $95.8K.
  • Teladoc Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4056 holding.
  • Citigroup first reported a position in Teladoc Health in Q3 2015 and has held it in 42 quarters since.
  • Citigroup's Teladoc Health position peaked at $115M in Q3 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.